Who We Are
Our Platform
- Posters & Publications
Our Pipeline
- Inflammatory Diseases
Patients, Families & Physicians
Investors & Media

Careers
Contact Us

Skip to main content
Skip to footer

Click here to read our Frontiers in Immunology paper on the small intestinal axis

Evelo

Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy

Home/Publications/Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy

November 27, 2015 by

Footer

Terms of Use/Privacy Policy

© Evelo Biosciences, Inc.
EVELO is a registered U.S. trademark of Evelo Biosciences, Inc.

Follow Us LinkedIn